Ò»¾º¼¼

English Ò»¾º¼¼¼¯ÍÅÆóÒµÓÊÏä

ÌìÏÂÉúÃü¿ÆÑ§Ç°Ñض¯Ì¬Öܱ¨£¨°Ëʮһ£©

2012Äê-06ÔÂ-30ÈÕ ÈªÔ´£ºmebo

£¨6.24-6.30/2012£©
Ò»¾º¼¼¹ú¼Ê¼¯ÍÅ:ÌÕ¹úР


¡¡¡¡Ö÷ÒªÄÚÈÝ£ºÐ¡·Ö×ÓDNAÊÊÌåÔö½øÉñ¾­ËèÇʵÄÔÙÉúºÍÐÞ¸´£»Ê³ÎïÏËά¸Ä±ä賦µÀ¾úȺÔö½øÎ¸³¦¿µ½¡£»¼¡ÓªÑø²»Á¼¼²²¡LGMD2DµÄ×ÔÌåϸ°ûÒÆÖ²£»¸Éϸ°ûºÍ°©Ï¸°ûÖжËÁ£Ã¸µÄµ÷Àí£»Ô´ÓÚÈËÅßÌ¥¸Éϸ°ûµÄÒÈÏÙ×æÏ¸°û·¢Óý³ÉÓй¦Ð§µÄÒȵºÖÎÁÆÀÏÊóµÄÌÇÄò²¡£»°þ¶áÆÏÌÑÌǼ¤»î´úлºÍÐźŵķŴó»ØÂ·µ¼ÖÂϸ°ûéæÃü¡£

¡¡¡¡½¹µã¶¯Ì¬£ºÐ¡·Ö×ÓDNAÊÊÌåÔö½øÉñ¾­ËèÇʵÄÔÙÉúºÍÐÞ¸´¡£

1.  С·Ö×ÓDNAÊÊÌåÔö½øÉñ¾­ËèÇʵÄÔÙÉúºÍÐÞ¸´

¡¾¶¯Ì¬¡¿¶à·¢ÐÔÓ²»¯²¡ÊÇÒ»ÖÖÖÐÊàÉñ¾­ÏµÍ³Ñ×Ö¢£¬»á¾Ö²¿ÆÆËð°ü¹üÉñ¾­ÖáÍ»µÄ¾øÔµµÄËèÇÊ£¬Ê¹ÈËÌåÔ½À´Ô½ÐéÈõ¡£È«ÌìÏÂÓÐ20¶àÍò¶à·¢ÐÔÓ²»¯²¡ÈË£¬¶øÈ±·¦Ô¤·À²¡ÇéÏ£ÍûºÍÓÕµ¼ÐÞ¸´µÄÖÎÁÆÊÖ¶Îʹ¸Ã²¡ºÜÊǼ¬ÊÖ¡ £¿¹Ñ×ÁÆ·¨Ö»ÔÚÔ¤·À¸´·¢·½ÃæÓÐÓÐÏÞЧ¹û¡£ÒÔǰËù×öµÄÈËѪÇåÑù±¾µÄɸ²éÏÔʾ×ÔÈ»IgM¿¹ÌåÍŽáÉÙͻϸ°û£¬ÔÚÄÔ¼¹ËèÑ×Ì©ÀÕ²¡¶¾ÂýÐÔѬȾµÄÒ׸ÐÀÏÊóÄ£×Ӻ;ֲ¿ÍÑËèÇÊ×÷ÓõÄÈÜѪÂÑÁ×֬ģ×ÓÖÐÔö½øÏ¸°ûÐźŴ«µ¼²¢¶ÔÖÐÊàÉñ¾­ÏµÍ³ÔÙËèÇÊ»¯¡£Õâ¸öÓÐȤµÄЧ¹ûÅú×¢Äܹ»ÌØÒìÍŽáÉÙͻϸ°û»òËèÇÊ×é·ÖµÄ·Ö×Ó¿ÉÄÜ»áÔö½ø¶à·¢ÐÔÓ²»¯²¡µÄÖÎÁÆÐÔËèÇÊÔÙÉú¡£¼øÓÚIgM¿¹ÌåÌ«´óÌ«ÖØ´ó£¬ÓÐÐëҪѰÕÒ¸üСµÄÄܹ»ÔÚÌåÄÚÔö½øËèÇÊÔÙÉúµÄËèÇÊÌØÒìÐÔ·Ö×Ó¡£ÃÀ¹ú¿ÆÑ§¼Ò×î½üµÄÑо¿ÏÔʾɸѡ³öµÄÌØÒìÍŽáÀÏÊóËèÇʵÄÒ»ÖÖ40¸öºËÜյĵ¥Á´DNAÊÊÌå¾ßÓÐÕâÖÖÌØÕ÷¡£¸ÃDNAÊÊÌåÔÚÌåÍâÄÜÓëËèÇʵĶà¸ö×é·Ö͎ᣬ¸¹Ç»×¢ÉäµÄ¸ÃÊÊÌåÄܹ»ÂþÑܵ½ÖÐÊàÉñ¾­×éÖ¯²¢Ôö½øÌ©ÀÕ²¡¶¾Ñ¬È¾µÄÀÏÊóÊÜËðµÄÄ£×ÓÖÐÊàÉñ¾­ÏµÍ³ËèÇÊÔÙÉú¡£Ïà¹ØÓÚµ¥¿Ë¡¿¹Ì壬DNAÊÊÌå¸üС£¬¸üÎȹÌ£¬Ã»ÓÐÃâÒßÔ­ÐÔ£¬ÓÐÍû³ÉΪеÄÖÎÁƶ෢ÐÔÓ²»¯µÄÊֶΡ£

¡¾µãÆÀ¡¿ ¸ÃÑо¿·¢Ã÷µÄС·Ö×ÓDNAÄܹ»Ìæ»»IgM¿¹ÌåÔÚÀÏÊóÄ£×ÓÖÐÔö½øÉñ¾­ËèÇʵÄÔÙÉúºÍÐÞ¸´£¬ÓпÉÄܳÉΪÖÎÁÆÈËÀà¶à·¢ÐÔÓ²»¯²¡µÄÑ¡Ï¿ÉÊÇ»¹ÐèÒªÔÚÆäËûµÄ¶¯ÎïÄ£×ÓÉÏÈ·ÈÏÆäÄÜ·ñ³ÉΪÈËÌåÁÙ´²ÊµÑéµÄºòÑ¡Îï¡£

¡¾²Î¿¼ÂÛÎÄ¡¿   
PLoS ONE, 2012; 7 (6): e39595 DOI: 10.1371/journal.pone.0039595
Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis
Branislav Nastasijevic, Brent R. Wright, John Smestad, et al.
Multiple sclerosis (MS) is a debilitating inflammatory disease of the central nervous system (CNS) characterized by local destruction of the insulating myelin surrounding neuronal axons. With more than 200 million MS patients worldwide, the absence of treatments that prevent progression or induce repair poses a major challenge. Anti-inflammatory therapies have met with limited success only in preventing relapses. Previous screening of human serum samples revealed natural IgM antibodies that bind oligodendrocytes and promote both cell signaling and remyelination of CNS lesions in an MS model involving chronic infection of susceptible mice by Theiler¡¯s encephalomyelitis virus and in the lysolecithin model of focal demyelination. This intriguing result raises the possibility that molecules with binding specificity for oligodendrocytes or myelin components may promote therapeutic remyelination in MS. Because of the size and complexity of IgM antibodies, it is of interest to identify smaller myelin-specific molecules with the ability to promote remyelination in vivo. Here we show that a 40-nucleotide single-stranded DNA aptamer selected for affinity to murine myelin shows this property. This aptamer binds multiple myelin components in vitro. Peritoneal injection of this aptamer results in distribution to CNS tissues and promotes remyelination of CNS lesions in mice infected by Theiler¡¯s virus. Interestingly, the selected DNA aptamer contains guanosine-rich sequences predicted to induce folding involving guanosine quartet structures. Relative to monoclonal antibodies, DNA aptamers are small, stable, and non-immunogenic, suggesting new possibilities for MS treatment.

 2. ʳÎïÏËά¸Ä±ä賦µÀ¾úȺÔö½øÎ¸³¦¿µ½¡

¡¾¶¯Ì¬¡¿ÃÀ¹ú¿ÆÑ§¼ÒµÄ×îÐÂÑо¿ÅúעʳÎïÏËάÄܹ»Ôö½øÎ¸³¦µÀ²î±ðÀàÐÍÓÐÒæ¾úȺµÄ×ÌÉú£¬¶øÕâЩÓÐÒæ¾úȺ¾ÝÐŲ»Ö¹Äܹ»Ôö½øÎ¸³¦µÀµÄ¿µ½¡£¬»¹Äܹ»Ó°ÏìÎÒÃǶԶàÖÖ¼²²¡µÄÃô¸ÐÐÔ£¬ºÃ±È2ÐÍÌÇÄò²¡¡¢·ÊÅÖ¡¢Ñ×Ö¢ÐÔ³¦²¡¡¢½á³¦°©ÒÔ¼°ÃâÒßÐÔ¼²²¡ÏñÀà·çʪÐÔÊàŦÑס£ÕâЩÓÐÒæ¾úȺÔÚ³¦µÀ·¢½ÍÏËά£¬ÖÆÔì¶ÌÁ´Ö¬·¾ËáºÍÆäËû´úл²úÆ·£¬¶ÔËÞÖ÷±¬·¢Öî¶à¿µ½¡·½ÃæµÄÒæ´¦¡£ÈôÊÇÄܹ»ÏàʶÄÄÖÖʳÎïÏËάÄܹ»×îºÃµÄ×ÌÑøÕâЩÔö½ø¿µ½¡µÄ¾úȺ£¬¾ÍÄܹ»¾ÀÕýÒûʳºÍ³¦µÀ¾úȺµÄ²»Æ½ºâ£¬Ö§³ÖºÍÔö½øÎ¸³¦µÀ¿µ½¡¡£¸ÃÑо¿ÅúעʳÎïÏËά³ýÁËÔö½øÎ¸³¦È䶯£¬¶ÔÈËÌåÉÐÓиü¶àÀûÒæ¡£ËûÃǾÙÐÐÁËÓÐο½å¼Á±ÈÕÕµÄ˫äÊÔÑ飬ÌìÌì¸øÓëÊÜÊÔÖ°Ô±²î±ðÖÖÀàµÄÔö²¹ÏËά£¨¾ÛÆÏÌÑÌÇ»ò¿ÉÈÜÐÔ¹ÈÎïÏËά£©£¬ÔÚµÚ16-21Ì죬¼ì²éÆä´ó±ãÑùÆ·ÖоúȺµÄ¡°Ö¸ÎÆÍ¼Æ×¡±¡£Á½ÖÖÏËά¶¼ÔÚÃÅÖÖÊôˮƽÉÏÓ°Ïì¾úȺµÄÊýÄ¿¡£Ôö²¹¿ÉÈÜÐÔ¹ÈÎïÏËάµÄÈË£¬Æä³¦µÀÒæÉú¾úÈéËá¸Ë¾úµÄÊýÄ¿ÔöÌí¡£Ôö²¹¾ÛÆÏÌÑÌÇ»ò¿ÉÈÜÐÔ¹ÈÎïÏËάµÄÈ˶¼ÄÜÔöÌí³¦µÀÓÐÒæ¾úȺ¡£Òò´Ë£¬¾ÛÆÏÌÑÌÇ»ò¿ÉÈÜÐÔ¹ÈÎïÏËάÓÐDZÁ¦×÷ÎªÒæÉúԪʹÓÃÔö½ø³¦µÀÒæÉú¾úµÄ×ÌÉú¡£

¡¾µãÆÀ¡¿ ¸ÃÑо¿ÅúעʳÎïÏËά²»µ«½öÊÇ×ÊÖúÈËÌåÔö½øÎ¸³¦È䶯ºÍʳÎïÏû»¯£¬²¢ÇÒÊÇÈËÌåºÜÖ÷ÒªµÄÓªÑøÎïÖÊ£¬¼ä½Óͨ¹ý×ÌÑø³¦µÀÒæÉú¾úÔö½øÈËÌ念½¡¡£

¡¾²Î¿¼ÂÛÎÄ¡¿   
Journal of Nutrition, 2012; 142 (7): 1259 DOI: 10.3945/jn.112.158766
454 Pyrosequencing Reveals a Shift in Fecal Microbiota of Healthy Adult Men Consuming Polydextrose or Soluble Corn Fiber
S. Hooda, B. M. V. Boler, M. C. R. Serao, et al.
The relative contribution of novel fibers such as polydextrose and soluble corn fiber (SCF) to the human gut microbiome and its association with host physiology has not been well studied. This study was conducted to test the impact of polydextrose and SCF on the composition of the human gut microbiota using 454 pyrosequencing and to identify associations among fecal microbiota and fermentative end-products. Healthy adult men (n = 20) with a mean dietary fiber (DF) intake of 14 g/d were enrolled in a randomized, double-blind, placebo-controlled crossover study. Participants consumed 3 treatment snack bars/d during each 21-d period that contained no supplemental fiber (NFC), polydextrose (PDX; 21 g/d), or SCF (21 g/d) for 21 d. There were no washout periods. Fecal samples were collected on d 16¨C21 of each period; DNA was extracted, followed by amplification of the V4-V6 region of the 16S rRNA gene using barcoded primers. PDX and SCF significantly affected the relative abundance of bacteria at the class, genus, and species level. The consumption of PDX and SCF led to greater fecal Clostridiaceae and Veillonellaceae and lower Eubacteriaceae compared with a NFC. The abundance of Faecalibacterium,Phascolarctobacterium, and Dialister was greater (P < 0.05) in response to PDX and SCF intake, whereas Lactobacillus was greater (P < 0.05) only after SCF intake.Faecalibacterium prausnitzii, well known for its antiinflammatory properties, was greater (P < 0.05) after fiber consumption. Principal component analysis clearly indicated a distinct clustering of individuals consuming supplemental fibers. Our data demonstrate a beneficial shift in the gut microbiome of adults consuming PDX and SCF, with potential application as prebiotics.

 3.  ¼¡ÓªÑø²»Á¼¼²²¡LGMD2DµÄ×ÔÌåϸ°ûÒÆÖ²

¡¾¶¯Ì¬¡¿Ò»ÏîÅ·ÖÞºÍÈÕ±¾¿ÆÑ§¼Ò¼ÓÈëµÄ×îÐÂÑо¿ÏÔʾԴÓÚÒ»ÖÖÓÐÊýµÄ¼¡ÓªÑø²»Á¼Ö¢»¼ÕߵĸÉϸ°û±»ÀÖ³ÉÒÆÖ²ÈëÓÐͬÑùÖ¢×´µÄÀÏÊóÄ£×ÓÖС£  Mesoangioblast£¨Ò»ÖÖÓëѪ¹ÜÓйصĸÉϸ°û£©¸É/×æÏ¸°ûÊÇÔ´ÓÚ±í´ï¼îÐÔÁ×ËáøµÄ¼¡ÈâÖз¢Ã÷µÄÖÜÆ¤Ï¸°ûÑÇȺ£¬ÒÑÏÔʾ³öÔÚ¼¡ÓªÑø²»Á¼Ö¢µÄ²î±ð¶¯ÎïÄ£×ÓÖиÄÉÆÖ¢×´µÄ×÷Ó㬲¢ÕýÔÚ»¼ÓжÅÐ˼¡ÓªÑø²»Á¼»¼¶ùÖоÙÐÐÁÙ´²²âÊÔ¡£»¼ÓÐÏà¹Ø¼¡ÓªÑø²»Á¼¼²²¡LGMD2DµÄ·¢²¡Ôµ¹ÊÔ­ÓÉÊDZàÂë¦Á-¼¡ÌÇ µÄ»ùÒò±¬·¢Í»±ä£¬ÖÜÆ¤Ï¸°ûïÔÌ­£¬²»¿É±¬·¢×ã¹»×ÔÌåϸ°ûÖÎÁƵÄMesoangioblast¡£Òò´Ë£¬¸ÃÑо¿´ÓLGMD2D»¼ÕߵijÉÏËάϸ°ûºÍ³É¼¡Ï¸°ûÖØ±à³Ì³ÉiPSC£¬²¢½¨ÉèÒ»Ì׳ÌÐò´ÓiPSC ת»¯³ÉMesoangioblastÑùϸ°û£¬Í¨¹ýÔÚÌåÍâ»ùÒòÐÞÕý²¢À©Ôö¸ÃÔ´ÓÚiPSCµÄMesoangioblastϸ°û£¬È»ºó½«ÆäÒÆÖ²µ½Ã»ÓЦÁ-¼¡ÌǵÄÃâÒßȱÏÝÀÏÊó£¬ËüÃDZ¬·¢Á˱í´ï¦Á-¼¡Ìǵļ¡ÏËά¡£¶ø½«Ô´ÓÚÀÏÊóiPSCµÄMesoangioblastϸ°ûÒÆÖ²µ½Ã»ÓЦÁ-¼¡ÌǵÄÃâÒßȱÏÝÀÏÊó¸ÄÉÆÁËÖ¢×´£¬»Ö¸´ÁËȱʧµÄ×æÏ¸°û¡£

¡¾µãÆÀ¡¿ ¸ÃÑо¿Ð§¹ûÒâζ×ÅÒÆÖ²»ùÒòÐÞÕýºóµÄÔ´ÓÚLGMD2D»¼ÕßiPSCµÄMesoangioblastÑùϸ°û¿ÉÄܶԸÃÖÖÒÔ¼°ÆäËûÖÖÀàµÄ¼¡ÓªÑø²»Á¼µÄÖÎÁÆÓÐÓá£

¡¾²Î¿¼ÂÛÎÄ¡¿   
Sci Transl Med, 27 June 2012 DOI: 10.1126/scitranslmed.3003541
Transplantation of Genetically Corrected Human iPSC-Derived Progenitors in Mice with Limb-Girdle Muscular Dystrophy
Francesco Saverio Tedesco, Mattia F. M. Gerli, Laura Perani, et al.  
Mesoangioblasts are stem/progenitor cells derived from a subset of pericytes found in muscle that express alkaline phosphatase. They have been shown to ameliorate the disease phenotypes of different animal models of muscular dystrophy and are now undergoing clinical testing in children affected by Duchenne¡¯s muscular dystrophy. Here, we show that patients with a related disease, limb-girdle muscular dystrophy 2D (LGMD2D), which is caused by mutations in the gene encoding ¦Á-sarcoglycan, have reduced numbers of this pericyte subset and thus produce too few mesoangioblasts for use in autologous cell therapy. Hence, we reprogrammed fibroblasts and myoblasts from LGMD2D patients to generate human induced pluripotent stem cells (iPSCs) and developed a protocol for the derivation of mesoangioblast-like cells from these iPSCs. The iPSC-derived mesoangioblasts were expanded and genetically corrected in vitro with a lentiviral vector carrying the gene encoding human ¦Á-sarcoglycan and a promoter that would ensure expression only in striated muscle. When these genetically corrected human iPSC-derived mesoangioblasts were transplanted into ¦Á-sarcoglycan¨Cnull immunodeficient mice, they generated muscle fibers that expressed ¦Á-sarcoglycan. Finally, transplantation of mouse iPSC-derived mesoangioblasts into ¦Á-sarcoglycan¨Cnull immunodeficient mice resulted in functional amelioration of the dystrophic phenotype and restoration of the depleted progenitors. These findings suggest that transplantation of genetically corrected mesoangioblast-like cells generated from iPSCs from LGMD2D patients may be useful for treating this type of muscular dystrophy and perhaps other forms of muscular dystrophy as well.

 4. ¸Éϸ°ûºÍ°©Ï¸°ûÖжËÁ£Ã¸µÄµ÷Àí

¡¾¶¯Ì¬¡¿µÂ¹ú¿ÆÑ§¼Ò×î½ü·¢Ã÷ÁËWnt/¦Â-ÁªÂѰ×ÐźÅ;¾¶Óë¶ËÁ£Ã¸ÑÇ»ù Tert±í´ïÖ®¼äµÄ·Ö×ÓÁªÏµ¡£¶ËÁ£Ã¸µÄ»îÐÔ¿ØÖÆ×ŶËÁ£³¤¶È£¬ÔÚ¸Éϸ°û£¬ÐàÂõºÍ°©Ö¢ÖÐÆðÒªº¦×÷ÓᣦÂ-ÁªÂѰ×ȱÏݵÄÀÏÊóÅßÌ¥¸Éϸ°û¶ËÁ£½Ï¶Ì£¬Ïà·´µØ£¬±í´ïÓлîÐԵĦÂ-ÁªÂѰ׵ÄÅßÌ¥¸Éϸ°ûÆä¶ËÁ£½ÏÁ¿³¤¡£Ñо¿Åú×¢¦Â-ÁªÂѰ×ͨ¹ýÓë¶àÄÜÐÔ×ªÂ¼ÍøÂçµÄ½¹µã×é·ÖKlf4Ï໥×÷Óõ÷ÀíTert±í´ï£¬ÔÚÀÏÊ󳦰©Ä£×ÓºÍÈËÌ尩ϸ°ûÖЦÂ-ÁªÂѰ×ÍŽᵽTertÔö½ø×Ó£¬Ö±½Óµ÷Àí¶ËÁ£Ã¸»ùÒò¡£µ÷Àí¹ýʧ»ò¦Â-ÁªÂѰ×Í»±ä»áµ¼ÖÂÖ×Áö±¬·¢¡£

¡¾µãÆÀ¡¿ ¸ÃÑо¿¹ØÓÚ¦Â-ÁªÂѰ׵÷ÀíTert±í´ï½ø¶øµ÷Àí¶ËÁ£Ã¸»îÐԺͶËÁ£³¤¶ÈµÄ·¢Ã÷¹ØÓÚ¸Éϸ°ûµÄÑо¿ÒÔ¼°¿¹°©Ñо¿¿ÉÄܱ¬·¢Ö÷ÒªÓ°Ïì¡£

¡¾²Î¿¼ÂÛÎÄ¡¿   
Science, 2012; 336 (6088): 1549 DOI: 10.1126/science.1218370
Wnt/ -Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells
K. Hoffmeyer, A. Raggioli, S. Rudloff, et al.  
Telomerase activity controls telomere length and plays a pivotal role in stem cells, aging, and cancer. Here, we report a molecular link between Wnt/¦Â-catenin signaling and the expression of the telomerase subunit Tert. ¦Â-Catenin¨Cdeficient mouse embryonic stem (ES) cells have short telomeres; conversely, ES cell expressing an activated form of ¦Â-catenin (¦Â-cat¦¤Ex3/+) have long telomeres. We show that ¦Â-catenin regulates Tert expression through the interaction with Klf4, a core component of the pluripotency transcriptional network. ¦Â-Catenin binds to the Tert promoter in a mouse intestinal tumor model and in human carcinoma cells. We uncover a previously unknown link between the stem cell and oncogenic potential whereby ¦Â-catenin regulates Tert expression, and thereby telomere length, which could be critical in human regenerative therapy and cancer.

 5. Ô´ÓÚÈËÅßÌ¥¸Éϸ°ûµÄÒÈÏÙ×æÏ¸°û·¢Óý³ÉÓй¦Ð§µÄÒȵºÖÎÁÆÀÏÊóµÄÌÇÄò²¡

¡¾¶¯Ì¬¡¿¼ÓÄôó¿ÆÑ§¼Ò×î½ü±¨µÀÁËÒ»Ì׼ƻ®£¬¿ÉÒÔʹÉÌÒµ»¯µÄÈËÌåÅßÌ¥¸Éϸ°ûÌåÍâ·Ö½â³É¸»¼¯µÄPDX1+ÒÈÏÙ×æÏ¸°ûȺ£¬½ø¶øÔÚÌåÄÚ½øÒ»²½·¢Óý³ÉÊìΪÒÈÏÙÉøÍ¸Ï¸°û¡£Î´³ÉÊìµÄÒÈÏÙǰÌåϸ°û±»ÒÆÖ²µ½Á´ëåÃ¹ËØÓÕµ¼µÄÌÇÄò²¡ÃâÒßȱÏÝÀÏÊ󣬶ø×î³õͨ¹ýÍâÔ´ÐÔÒȵºËØ¿ØÖƸßѪÌÇÖ¢×´£¬Ëæ×ÅÒÆÖ²Ï¸°û±¬·¢µÄÒȵºËØËæÊ±¼äµÄÔöÌí£¬ÌÇÄò²¡ÀÏÊóÖ𽥿ÉÒÔÍÑÀëÍâÔ´ÐÔÒȵºËØ£¬ÈËC-ëĵÄÉøÍ¸×îÖÕ¿ÉÒÔͨ¹ýÒûʳºÍÆÏÌÑÌÇÄÍÊܵ÷Àí¡£ÔÚÃâÒßȱÏݵÄÃ÷È·ÊóÖÐÒ²ÊӲ쵽ÁËÀàËÆµÄÒÈÏÙ×æÏ¸°ûµÄ·Ö½â£¬ÌåÄÚÔ´ÓÚÈËÌåÅßÌ¥¸Éϸ°ûµÄÉøÍ¸Ï¸°ûµÄ³ÉÊìÀú³ÌÖзºÆðµÄ»ùÒòºÍÂѰױí´ïÏÔ×ÅÀàËÆÓÚÈËÌåÅßÌ¥·¢ÓýÖеÄÒÈÏÙ¡£

¡¾µãÆÀ¡¿ ¸ÃÑо¿·¢Ã÷µÄЧ¹ûÖ§³ÖʹÓ÷ֽâµÄÈËÌåÅßÌ¥¸Éϸ°ûÖÎÁÆÌÇÄò²¡µÄ¿ÉÄÜÐÔ£¬¿ÉÊÇÓÉÓÚ´ËÀàµÄ¶¯ÎïÊÔÑé¶¼ÊÇʹÓò»´óÇãÔþϸ°ûÒÆÖ²µÄÃâÒßȱÏݶ¯ÎïÄ£×Ó¾ÙÐеÄ£¬ÏÔ×Ųî±ðÓÚÕý³£µÄÉúÃü£¬Òò´ËÆäÊÔÑéЧ¹ûÒ²Ö´ÙÇÌṩijÖÖ¿ÉÄÜÐԵIJο¼£¬²¢²»¾ß±¸ÏÖʵÒâÒå¡£

¡¾²Î¿¼ÂÛÎÄ¡¿   
Diabetes, June 27, 2012 DOI:10.2337/db11-1711
Maturation of Human Embryonic Stem Cell¨CDerived Pancreatic Progenitors into Functional Islets Capable of Treating Pre-existing Diabetes in Mice
Alireza Rezania, Jennifer E. Bruin, Michael J. Riedel, et al.
Diabetes is a chronic debilitating disease that results from insufficient production of insulin from pancreatic ¦Â-cells. Islet cell replacement can effectively treat diabetes but is currently severely limited by the reliance upon cadaveric donor tissue. We have developed a protocol to efficiently differentiate commercially available human embryonic stem cells (hESCs) in vitro into a highly enriched PDX1+ pancreatic progenitor cell population that further develops in vivo to mature pancreatic endocrine cells. Immature pancreatic precursor cells were transplanted into immunodeficient mice with streptozotocin-induced diabetes, and glycemia was initially controlled with exogenous insulin. As graft-derived insulin levels increased over time, diabetic mice were weaned from exogenous insulin and human C-peptide secretion was eventually regulated by meal and glucose challenges. Similar differentiation of pancreatic precursor cells was observed after transplant in immunodeficient rats. Throughout the in vivo maturation period hESC-derived endocrine cells exhibited gene and protein expression profiles that were remarkably similar to the developing human fetal pancreas. Our findings support the feasibility of using differentiated hESCs as an alternative to cadaveric islets for treating patients with diabetes.

 6. °þ¶áÆÏÌÑÌǼ¤»î´úлºÍÐźŵķŴó»ØÂ·µ¼ÖÂϸ°ûéæÃü

¡¾¶¯Ì¬¡¿°©Ï¸°û±äÒìµÄ´úлÈÃϸ°ûÉúÑÄÒÀÀµÓÚ´úлµ×ÎïµÄ±£´æ¡£ÃÀ¹ú¿ÆÑ§¼Òͨ¹ýÑо¿ÒÀÀµÆÏÌÑÌÇÉúÑĵÄϸ°ûéæÃüµÄÐźŻúÖÆÆÊÎöѸËÙ°þ¶áÆÏÌÑÌǹ©Ó¦µ¼Ö³¬Õý³£ÐÄÀíˮƽµÄÁ×ËữÀÒ°±ËáÐźÅ£¬ÉõÖÁÊÇÔÚ±í´ï½á¹¹ÉÏ»îÔ¾µÄÀÒ°±ËἤøµÄϸ°ûÀͨ¹ý¿Í¹ÛµÄ»ùÓÚÖÊÆ×µÄÁ×ËữÂÑ°×Æ×£¬¸ÃÑо¿·¢Ã÷°þ¶áÆÏÌÑÌǼ¤»îÆô¶¯ÁËÓë¾Ö²¿ÅþÁ¬ÓÐ¹ØµÄÆæÒìµÄÁ×ËữÀÒ°±ËáÊðÃû£¬¼¤»îÁËÉæ¼°NADPHºÍÏßÁ£ÌåÉú²ú»îÐÔÑõ£¬Ñõ»¯ÒÖÖÆÀÒ°±ËáÂѰ×Á×Ëữø£¬ÒÔ¼°ÔöÌíÀÒ°±ËἤøÐźŵÄÕý·´Ïì»ØÂ·£¬×îÖÕµ¼Ö»îÐÔÑõ½éµ¼µÄϸ°ûéæÃü¡£

¡¾µãÆÀ¡¿ ¸ÃÑо¿ËµÃ÷Îú°©Ï¸°ûά³Ö¶¯Ì¬Æ½ºâÀú³ÌÖдúлºÍÐźÅÔÚϵͳˮƽÉϵĽ»Á÷¡£°þ¶áÆÏÌÑÌÇÓÕÉúÑÄÐÔÑõ£¬ÒÖÖÆÁ×Ëữø£¬¼¤»îÀÒ°±Ëἤøת¶ø±¬·¢¸ü¶à»îÐÔÑõ£¬Õý·´ÏìµÄ»ØÂ·Ò»Ö±·Å´ó»îÐÔÑõˮƽֱÖÁϸ°û¾ÙÐлîÐÔÑõ½éµ¼µÄϸ°ûéæÃü¡£

¡¾²Î¿¼ÂÛÎÄ¡¿   
Molecular Systems Biology, 2012; 8 DOI: 10.1038/msb.2012.20
Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death
Nicholas A Graham, Martik Tahmasian, Bitika Kohli, et al.    
The altered metabolism of cancer can render cells dependent on the availability of metabolic substrates for viability. Investigating the signaling mechanisms underlying cell death in cells dependent upon glucose for survival, we demonstrate that glucose withdrawal rapidly induces supra-physiological levels of phospho-tyrosine signaling, even in cells expressing constitutively active tyrosine kinases. Using unbiased mass spectrometry-based phospho-proteomics, we show that glucose withdrawal initiates a unique signature of phospho-tyrosine activation that is associated with focal adhesions. Building upon this observation, we demonstrate that glucose withdrawal activates a positive feedback loop involving generation of reactive oxygen species (ROS) by NADPH oxidase and mitochondria, inhibition of protein tyrosine phosphatases by oxidation, and increased tyrosine kinase signaling. In cells dependent on glucose for survival, glucose withdrawal-induced ROS generation and tyrosine kinase signaling synergize to amplify ROS levels, ultimately resulting in ROS-mediated cell death. Taken together, these findings illustrate the systems-level cross-talk between metabolism and signaling in the maintenance of cancer cell homeostasis.
 

ÍøÕ¾µØÍ¼